{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:10Z","timestamp":1760028550184},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-480","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T09:03:37Z","timestamp":1406624617000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Myocardial injury in a 41-year-old male treated with methylphenidate: a case report"],"prefix":"10.1186","volume":"7","author":[{"given":"Lisa Drange","family":"Hole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Schj\u00f8tt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,29]]},"reference":[{"key":"3016_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1176\/appi.ajp.2011.11010125","volume":"169","author":"H Schelleman","year":"2012","unstructured":"Schelleman H, Bilker WB, Kimmel SE, Daniel GW, Newcomb C, Guevara JP, Cziraky MJ, Strom BL, Hennessy S: Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry. 2012, 169: 178-185.","journal-title":"Am J Psychiatry"},{"key":"3016_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuropharm.2012.07.005","volume":"64","author":"BE Schmeichel","year":"2013","unstructured":"Schmeichel BE, Zemlan FP, Berridge CW: A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder. Neuropharmacology. 2013, 64: 321-328.","journal-title":"Neuropharmacology"},{"key":"3016_CR3","first-page":"687","volume":"108","author":"K Wenzel-Seifert","year":"2011","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E: QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int. 2011, 108: 687-693.","journal-title":"Dtsch Arztebl Int"},{"key":"3016_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/pds.1399","volume":"16","author":"WN Kelly","year":"2007","unstructured":"Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP, International Society of Pharmacoepidemiology: Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf. 2007, 16: 581-587. 10.1002\/pds.1399.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3016_CR5","first-page":"171","volume":"13","author":"CW Hamm","year":"2012","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, European Society of Cardiology: [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol. 2012, 13: 171-228.","journal-title":"G Ital Cardiol"},{"key":"3016_CR6","volume-title":"Eur Psychiatry","author":"E Sobanski","year":"2013","unstructured":"Sobanski E, Retz W, Fischer R, Ose C, Alm B, Hennig O, Rosler M: Treatment adherence and persistence in adult ADHD: results from a twenty-four week controlled clinical trial with extended release methylphenidate. Eur Psychiatry. 2013"},{"key":"3016_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jemermed.2007.06.021","volume":"38","author":"J Thompson","year":"2010","unstructured":"Thompson J, Thompson JR: Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. J Emerg Med. 2010, 38: 18-21. 10.1016\/j.jemermed.2007.06.021.","journal-title":"J Emerg Med"},{"key":"3016_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199511093331907","volume":"333","author":"JE Hollander","year":"1995","unstructured":"Hollander JE: The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995, 333: 1267-1272. 10.1056\/NEJM199511093331907.","journal-title":"N Engl J Med"},{"key":"3016_CR9","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.108.843474","volume":"119","author":"S Stern","year":"2009","unstructured":"Stern S, Bayes de Luna A: Coronary artery spasm: a 2009 update. Circulation. 2009, 119: 2531-2534. 10.1161\/CIRCULATIONAHA.108.843474.","journal-title":"Circulation"},{"key":"3016_CR10","first-page":"647","volume":"174","author":"MH Ruwald","year":"2012","unstructured":"Ruwald MH, Ruwald AC, Tonder N: [Methylphenidate induced ST elevation acute myocardial infarction]. Ugeskr Laeger. 2012, 174: 647-648.","journal-title":"Ugeskr Laeger"},{"key":"3016_CR11","first-page":"E85","volume":"19","author":"G Bromberg-Marin","year":"2007","unstructured":"Bromberg-Marin G, Mahmud E, Tsimikas S: Spontaneous multivessel coronary vasospasm leading to cardiogenic shock. J Invasive Cardiol. 2007, 19: E85-E88.","journal-title":"J Invasive Cardiol"},{"key":"3016_CR12","doi-asserted-by":"publisher","first-page":"e000795","DOI":"10.1161\/JAHA.114.000795","volume":"3","author":"N Nakayama","year":"2014","unstructured":"Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, Yoshimura H, Mizobe M, Takashio S, Tsujita K, Kojima S, Tayama S, Hokimoto S, Sakamoto T, Nakao K, Sugiyama S, Kimura K, Ogawa H: Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. J Am Heart Assoc. 2014, 3: e000795-10.1161\/JAHA.114.000795.","journal-title":"J Am Heart Assoc"},{"key":"3016_CR13","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","volume":"50","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Joint ESCAAHAWHFTFftRoMI: Universal definition of myocardial infarction. J Am Coll Cardiol. 2007, 50: 2173-2195. 10.1016\/j.jacc.2007.09.011.","journal-title":"J Am Coll Cardiol"},{"key":"3016_CR14","first-page":"439","volume":"133","author":"MJ Zellweger","year":"2003","unstructured":"Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S: Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly. 2003, 133: 439-441.","journal-title":"Swiss Med Wkly"},{"key":"3016_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cjca.2010.12.004","volume":"27","author":"N Ben Yedder","year":"2011","unstructured":"Ben Yedder N, Roux JF, Paredes FA: Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011, 27: 105-109. 10.1016\/j.cjca.2010.12.004.","journal-title":"Can J Cardiol"},{"key":"3016_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MD.0b013e3181dddb3b","volume":"89","author":"GV Chow","year":"2010","unstructured":"Chow GV, Hirsch GA, Spragg DD, Cai JX, Cheng A, Ziegelstein RC, Marine JE: Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine. 2010, 89: 141-148. 10.1097\/MD.0b013e3181dddb3b.","journal-title":"Medicine"},{"key":"3016_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijcard.2004.05.076","volume":"102","author":"DP Redfearn","year":"2005","unstructured":"Redfearn DP, Ratib K, Marshall HJ, Griffith MJ: Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. Int J Cardiol. 2005, 102: 521-522. 10.1016\/j.ijcard.2004.05.076.","journal-title":"Int J Cardiol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:25:20Z","timestamp":1548213920000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,29]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3016"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-480","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,29]]},"assertion":[{"value":"13 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"480"}}